127 results

• Lawsuit Indicates Mounjaro Caused Gastroparesis, Severe Metabolic Acidosis Injuries

  July 29, 2025

  Irvin Jackson

  A Mounjaro lawsuit claims an Ohio woman suffered severe injuries due to a lack of warnings about the risks of stomach paralysis.

• Pancreatitis Risks From Ozempic, Mounjaro Being Investigated by U.K. Regulators

  July 15, 2025

  Irvin Jackson

  U.K. health regulators are urging users of drugs like Ozempic and Mounjaro to report cases of acute pancreatitis as part of an ongoing genetic investigation.

• NAION Ozempic Lawsuit Filed After User’s Eye Suffers 85% Vision Loss

  July 10, 2025

  Irvin Jackson

  Novo Nordisk is facing a lawsuit alleging it failed to adequately warn about the risk of vision loss from Ozempic, including cases of NAION (non-arteritic anterior ischemic optic neuropathy).

• Centralization of Ozempic, Wegovy NAION Lawsuits Sought in New Jersey State Court

  June 18, 2025

  Irvin Jackson

  At least 21 Ozempic and Wegovy lawsuits have been filed in New Jersey state court, involving allegations that users were left with vision loss from NAION after using the popular diabetes and weight loss drugs.

• Ozempic NAION Side Effects Result in Vision Loss Warnings by European Regulators

  June 9, 2025

  Irvin Jackson

  European regulators have determined that Ozempic and similar semaglutide-based drugs increase the risk of a rare vision disorder that can cause vision loss and blindness.

• Wegovy Lawsuit Alleges Vision Loss Side Effects Concealed by Novo Nordisk

  May 6, 2025

  Irvin Jackson

  A Wegovy lawsuit claims the weight loss drug's side effects caused him to suffer vision problems after a year of injections.

• More Than a Third of GLP-1 Drug Users Microdose To Avoid Side Effects, Survey Finds

  May 2, 2025

  Irvin Jackson

  Most users of Ozempic and similar drugs say they currently take microdoses of the medications or have done so in the past.

• Ozempic Blindness Lawsuit Claims Drug Caused NAION Side Effects

  April 28, 2025

  Irvin Jackson

  A new lawsuit claims that the diabetes and weight loss drug, Ozempic, caused a woman to lose vision in her left eye.

• Court Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks

  March 21, 2025

  Irvin Jackson

  Pushing back against a motion to dismiss, plaintiffs involved in GLP-1 lawsuits say GLP-1 manufacturers intentionally misled the medical community and patients regarding the safety of the diabetes and weight loss drugs.

• GLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing

  March 17, 2025

  Irvin Jackson

  Eli Lilly has filed a motion calling for a federal judge to put in place specific requirements for establishing a gastroparesis diagnosis in stomach paralysis lawsuits filed against the makers of Mounjaro, Ozempic and other GLP-1 medications.